Loading…
Anuh Pharma (ANUHPHR)₹82.78−0.01%Pharmaceuticals
Anuh Pharma is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 18.6 against a peer median of 38.2, and ROCE of 15.1% against a peer median of 13.9%, and latest-quarter sales growth of 4.3% against a peer median of 4.0%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sigachi Industries | 1,036 | 38.2 | 6.0 | 5.8 | 0.27 | 0.4 | 478 | −83 | −5.4 | — | vs ANUHPHR |
| Remus Pharmaceuticals | 968 | 26.2 | 17.1 | 12.3 | 0.08 | 0.1 | 853 | 46 | 30.2 | 19.1 | vs ANUHPHR |
| Themis Medicare | 939 | 23.5 | 3.0 | 0.4 | 0.25 | 0.5 | 342 | 1 | −11.1 | — | vs ANUHPHR |
| Shree Ganesh Remedies | 861 | 71.6 | 13.9 | 10.8 | 0.16 | 0.0 | 109 | 18 | −23.2 | −67.0 | vs ANUHPHR |
| Anuh Pharma | 828 | 18.6 | 15.1 | 10.7 | 0.00 | 1.8 | 776 | 41 | 4.3 | 37.6 | — |
| Aptus Pharma | 811 | 175.8 | 30.0 | 30.5 | 0.31 | 0.0 | 46 | 5 | 117.3 | 60.0 | vs ANUHPHR |
| Amanta Healthcare | 784 | 54.2 | 12.0 | 10.4 | 1.12 | 0.0 | 289 | 15 | 5.3 | −5.7 | vs ANUHPHR |
| Shree Ganesh Remedies | 779 | 50.4 | 14.0 | 10.9 | 0.19 | 0.0 | 109 | 18 | −41.8 | −67.3 | vs ANUHPHR |
| Zim Laboratories | 735 | 180.1 | 5.0 | 1.6 | 0.43 | 0.0 | 374 | 6 | 31.4 | — | vs ANUHPHR |
| Kilitch Drugs (India) | 701 | 23.2 | 13.1 | 10.5 | 0.32 | 0.0 | 235 | 30 | 4.0 | −13.6 | vs ANUHPHR |
| Wanbury | 700 | 10.4 | 31.1 | 68.4 | 1.56 | 0.0 | 648 | 66 | −4.1 | 10.0 | vs ANUHPHR |
| Peer median | 811 | 38.2 | 13.9 | 10.7 | 0.27 | 0.0 | 342 | 18 | 4.0 | 2.2 |
Listed companies closest to Anuh Pharma in Pharmaceuticals include Sigachi Industries, Remus Pharmaceuticals, Themis Medicare, Shree Ganesh Remedies, Aptus Pharma, Amanta Healthcare, Shree Ganesh Remedies, Zim Laboratories.
Sigachi Industries, with a market cap of ₹1,036 Cr.
Anuh Pharma trades at a P/E of 18.6; the median of its peer set is 38.2. A P/E above or below the median is a description, not a judgement on value.
Anuh Pharma's return on capital employed is 15.1%, above the peer median of 13.9%.